NL-OMON25189
招募中
不适用
A phase I study to investigate the safety of TEG001 cell suspension for infusion in patients with relapsed/refractory Acute Myeloid Leukemia, high-risk Myelodysplastic Syndrome (IPSS-R score >4,5) or Multiple Myeloma
概览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 18
概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age ¡Ý 18\-years
- •\- Relapsed/refractory Acute Myeloid Leukemia, high\-risk Myelodysplastic Syndrome (IPSS\-R score \>4,5\) or Multiple Myeloma, for which no remaining standard of care or approved treatment options are available
排除标准
- •\- In the investigators judgment, the subject is unlikely to complete all protocol\-required study visits or procedures
- •\- Central Nervous System involvement of the haematological malignancy
研究者
相似试验
招募中
不适用
A phase I study to investigate the safety of TEG001 cell suspension for infusion in patients with relapsed/refractory Acute Myeloid Leukemia/high-risk Myelodysplastic Syndrome (IPSS-R score >4,5) relapsed/refractory or Multiple MyelomaNL-OMON47707niversitair Medisch Centrum Utrecht18
招募中
1 期
Phase I study for the efficacy and the safety of the perioperative urinastatin therapy in chest surgical patients with interstitial pneumonia.interstitial pneumonia, lung cancer, metastatic lung tumor, pneumothoraxJPRN-UMIN000003295Tokyo Women's Medical University of Medicine, Department of Surgery I30
尚未招募
1 期
Investigating targEting LysyL oxIdase tO ameliorate scarring in burn Traumaburn injurySkin - Other skin conditionsInjuries and Accidents - BurnsACTRN12623001071617university of western australia60
终止
1 期
A first-in-human study of VG161 in participants with advanced malignant tumours that have not responded to conventional therapies.Advanced malignant solid tumorsCancer - Other cancer typesCancer - Any cancerACTRN12620000244909Virogin Biotech Australia Pty. Ltd.7
终止
1 期
This study is examining the safety and tolerability of a new drug (Everolimus) in combination with chemotherapy in the treatment of relapsed adult acute lymphobastic leukaemiaacute lymphobastic leukaemia (ALL)Cancer - Leukaemia - Acute leukaemiaACTRN12610000405011Australasian Leukaemia and Lymphoma Group20